Skip to content

Increasing Family Engagement in Critical Care

Increasing Family Engagement in Critical Care: The NGAGE Trial (The NGAGE Trial)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06586528
Acronym
NGAGE
Enrollment
194
Registered
2024-09-19
Start date
2025-03-26
Completion date
2027-09-30
Last updated
2025-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Care, Intensive Care, Family-centered Care, Family Engagement, Health Care Delivery, Patient and Family Engagement

Keywords

Patient- and Family-Centered Care, Family Engagement, Critical Care, Intensive Care Unit, Person-Centered Care, Delivery of Health Care

Brief summary

The primary aim of this trial is to evaluate if the NGAGE tool improves care engagement in family members of ICU patients. The secondary objectives are to assess if the NGAGE tool improves communication, care satisfaction, psychological symptoms, and quality of life in family members of ICU patients. The NGAGE trial is a stepped wedge cluster randomized trial of 6 Canadian adult ICUs, involving 194 family members. A family member will be considered anyone with a biological, emotional, or legal relationship with the patient and whom the patient wishes to be involved in their care. There will be random and sequential crossover of clusters from control (phase 1) to intervention (phase 2) until all clusters are exposed. The intervention group will have access to the NGAGE tool, which has modules to Learn, Engage, and Report. Engage allows the family member to indicate their desired engagement activity, which is then transmitted to the treating healthcare team to provide the requested activity. Learn contains educational capsules about the ICU environment and information about care participation. Report allows the family member to provide real-time feedback to the healthcare team. The primary endpoint is the FAMily Engagement (FAME) score within 1 week of ICU discharge. Secondary endpoints are family-centered outcomes, including communication quality, satisfaction, and mental health (anxiety and depression) scores within 1 week of ICU discharge, and quality of life and mental health (anxiety, depression, and post-traumatic distress symptoms) at 6 months. The mean difference of the validated FAME score, a continuous variable, will be compared between groups.

Interventions

Access to NGAGE tool

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Lady Davis Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

In the stepped-wedge cluster design, there is random and sequential crossover of clusters from control (phase 1) to intervention (phase 2) until all clusters are exposed

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult family members (age ≥ 18 years) of ICU patients * Expected ICU stay ≥ 48 hours * Able to participate in English or French

Exclusion criteria

* Family members who do not wish to participate in care * Repeat admissions within the study period * Another family member has already participated in the study

Design outcomes

Primary

MeasureTime frameDescription
FAMily Engagement (FAME) score within 1 week of ICU discharge1-week post-hospital dischargeThe FAMily Engagement (FAME) tool is a self-administered 12-item questionnaire that assesses an individual's current engagement practice. FAME uses a five-point Likert scale ranging from 1 (strongly agree) to 5 (strongly disagree), and scale results are changed to a 0-100 scoring system, with higher scores indicating greater engagement in care. The following subdomains are evaluated: engagement perception, family presence, communication, education, decision-making, care contribution, and family needs. FAME includes the following engagement domains: family presence, family needs, communication and education, decision making, and direct care. FAME also captures the following family-centered care principles: dignity and respect, information sharing, participation, and collaboration.

Secondary

MeasureTime frameDescription
Family satisfaction in the ICU (FS-ICU)1-week post-hospital dischargeThe Family Satisfaction in the ICU survey (FS-ICU) is a 24-item instrument that was developed and validated to assess family satisfaction and experience with care in the ICU. Scores range from 0 to 100, with higher scores indicate greater satisfaction.
Quality of communication (QOC score)1-week post-hospital dischargeThe Quality of Communication tool is a 13-item questionnaire that was developed and validated in an ICU setting to measure the perceived quality of communication. Scores range from 0 to 100, with higher scores indicating better clinician-family communication.
Anxiety and depression (HADS)1-week post-hospital dischargeThe Hospital Anxiety and Depression Scale (HADS) is a simple to use, validated, and widely used self-reported tool to measure anxiety and depression in medical patients. The survey is composed of 14 questions: 7 depression-related and 7 anxiety-related questions. The score for each item ranges from 0 to 3, and subscale scores greater than 8 denotes anxiety or depression.
Post-traumatic stress (IES-Revised)6 months post-hospital dischargeThe IES-Revised is a 22-item questionnaire that has been validated and is widely used for measuring post-traumatic stress symptoms and yields a total score ranging from 0 to 88 and subscale scores for the Intrusion, Avoidance, and Hyperarousal subscales. Items are rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely). High scores indicate greater severity of PTSD.
Quality of life (EuroQOL-5D-5L score)6 months post-hospital dischargeThe EuroQOL-5D-5L is a 5-item questionnaire that has been validated and is widely used for measuring health-related quality of life. Each dimension has five response levels: no problems (Level 1); slight; moderate; severe; and extreme problems (Level 5). The scores are combined to generate a single index value for overall health status. EQ-5D-5L index scores range from -0.59 to 1, where 1 is the best possible health state

Countries

Canada

Contacts

Primary ContactJillian Kifell, MSc
jillian.kifell.ccomtl@ssss.gouv.qc.ca5143408222

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026